Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Clinical trial NCT00940225 · COMPLETED
Trial details
- NCT number
- NCT00940225
- Sponsor
- Exelixis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-05-01
- Enrollment
- 730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.